Neuriva Brain Pill $8 Million Class Deal Gets Judge’s Nod

An $8 million false ad class settlement between Neuriva memory supplement consumers and Reckitt Benckiser LLC got a Florida federal judge’s final approval recommendation despite an objecting class member and a consumer advocacy group’s concern that the deal gives the class little besides a meaningless label change.

The settlement offers significant relief, Magistrate Judge Jonathan Goodman of the U.S. District Court for the Southern District of Florida said in a Wednesday report recommending final approval.

David Williams and others alleged Reckitt Benckiser and RB Health (US) LLC deceptively touted the brain booster as “backed by science” and “clinically proven” to ...